一个单一中心前性研究关于与老年门诊患者的多药学相关的药物不良反应
Maria Khurshid1, Ammarah Amjad2, Sundas Qamar3
1Pharmacology, Azad Jammu and Kashmir Medical College, Muzaffarabad, PAK.
Cureus
|January 6, 2026
概括
老年患者的多种药物经常导致不良药物反应 (ADR),影响门诊护理. 这项研究发现,超过30%的服用多种药物的老年患者出现了副作用,尤其是80岁以上的老年患者.
科学领域:
- 老年医学 老年医学
- 临床药理学 临床药理学
- 患者安全 患者安全
背景情况:
- 在老年人中,多种药物增加了药物不良反应 (ADR) 的风险.
- 在老年人中管理多种药物对安全的门诊护理提出了重大挑战.
研究的目的:
- 为了前性地评估老年门诊多药患者中ADRs的发生率,特征和临床后果.
- 在这个人群中识别与ADR相关的风险因素.
主要方法:
- 一项前性观察性研究,涉及246名老年门诊患者 (≥60岁) 使用五种或以上的药物.
- 通过医疗记录审查和患者访谈收集的数据;使用FDA毒性分级表分类的副作用.
- 使用SPSS v25.0进行的统计分析,P < 0.05被认为是显著的.
主要成果:
- 超过30% (76/246) 的患者至少经历过一次不良反应,胃肠道和皮肤系统受到影响最多.
- 副作用在80岁以上的患者,服用9种药物以上的患者和多种并发症患者 (P<0.05) 中明显更为普遍.
- 常见的并发病包括高血压,2型糖尿病和缺血性心脏病.
结论:
- 老年门诊患者的多药性与临床显著的副作用密切相关.
- 常规药物审查和勤奋的药物监测对于减轻与老年人多药性相关的风险至关重要.
相关概念视频
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
192
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
192
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
218
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
218
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
224
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229
